Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001477932-23-001311
Filing Date
2023-03-03
Accepted
2023-03-03 17:11:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 DFAN 14A kmph_dfan14a.htm DFAN14A 38680
  Complete submission text file 0001477932-23-001311.txt   40107
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Subject) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-36913 | Film No.: 23705630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2146 SWANSTONE CIRCLE DE PERE WI 54115
Business Address
Mangless Daniel John (Filed by) CIK: 0001779475 (see all company filings)

Type: DFAN14A